Trial · NCT01430442
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Treatment A: Rimegepant, 10 mg | 85 | |
| Overall Study | STARTED | Treatment B: Rimegepant, 25 mg | 68 | |
| Overall Study | STARTED | Treatment C: Rimegepant, 75 mg | 91 | |
| Overall Study | STARTED | Treatment D: Rimegepant, 150 mg | 90 | |
| Overall Study | STARTED | Treatment E: Rimegepant, 300 mg | 121 | |
| Overall Study | STARTED | Treatment F: Rimegepant, 600 mg | 92 | |
| Overall Study | STARTED | Treatment P: Rimegepant Placebo-Matching Capsules | 229 | |
| Overall Study | STARTED | Treatment G: Sumatriptan 100 mg | 109 | |
| Overall Study | COMPLETED | Treatment A: Rimegepant, 10 mg | 72 | |
| Overall Study | COMPLETED | Treatment B: Rimegepant, 25 mg | 62 | |
| Overall Study | COMPLETED | Treatment C: Rimegepant, 75 mg | 86 | |
| Overall Study | COMPLETED | Treatment D: Rimegepant, 150 mg | 86 | |
| Overall Study | COMPLETED | Treatment E: Rimegepant, 300 mg | 112 | |
| Overall Study | COMPLETED | Treatment F: Rimegepant, 600 mg | 84 | |
| Overall Study | COMPLETED | Treatment P: Rimegepant Placebo-Matching Capsules | 210 | |
| Overall Study | COMPLETED | Treatment G: Sumatriptan 100 mg | 100 | |
| Overall Study | NOT COMPLETED | Treatment A: Rimegepant, 10 mg | 13 | |
| Overall Study | NOT COMPLETED | Treatment B: Rimegepant, 25 mg | 6 | |
| Overall Study | NOT COMPLETED | Treatment C: Rimegepant, 75 mg | 5 | |
| Overall Study | NOT COMPLETED | Treatment D: Rimegepant, 150 mg | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01430442/flow